Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD?

被引:1
|
作者
Hagstrom, Hannes [1 ,2 ,3 ]
机构
[1] Karolinska Univ Hosp, Unit Hepatol, Dept Upper GI, Stockholm, Sweden
[2] Karolinska Inst, Unit Clin Epidemiol, Dept Med, Stockholm, Sweden
[3] Karolinska Inst, Dept Med, Stockholm, Sweden
关键词
LIVER-DISEASE;
D O I
10.1111/apt.15744
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
LINKED CONTENT This article is linked to Moolla et al and Moolla and Tomlinson papers. To view these articles, visit and .
引用
收藏
页码:1204 / 1205
页数:2
相关论文
共 50 条
  • [21] Evaluation of the efficacy of urine-based lipoarabinomannan antigen test in the diagnosis of pulmonary tuberculosis
    张天辉
    China Medical Abstracts(Internal Medicine), 2024, 41 (02) : 100 - 101
  • [22] A multicenter, prospective evaluation of a urine-based assay for bladder cancer diagnosis.
    Wang, Liang
    Liang, Yiming
    Shi, Min
    Ma, Tonghui
    Deng, Jianhua
    Ding, Degang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [23] USE OF LINEAR DISCRIMINANT ANALYSIS IN A URINE-BASED TEST FOR BLADDER CANCER DIAGNOSIS
    Wallace, Ellen
    Mach, Kathleen E.
    McCann, Leena
    Sin, Lai Yi Mandy
    Mohan, Ruchika
    Satya, Malini
    Wei, Huilin
    Zhang, Jun
    Lykke, Chris
    Higuchi, Russell
    Liao, Joseph C.
    JOURNAL OF UROLOGY, 2015, 193 (04): : E498 - E498
  • [24] Urine-based ELISA testing for the diagnosis and confirmation of eradication of Helicobacter pylori infection
    Dolek, D.
    Soyturk, M.
    Bekmen, N.
    Yilmaz, O.
    Demiray, E.
    Sarioglu, S.
    Ellidokuz, H.
    Simsek, I.
    HELICOBACTER, 2007, 12 (04) : 444 - 444
  • [25] Enhancing urine-based cfDNA detection for prostate cancer diagnosis through increased urine input volume
    Jafari, Nafiseh
    Dorn, Annika
    Saenz, Jason
    Lee, Lauren
    Hernandez, Carlos
    Dunnigan, Andrew
    Saidian, Mayer
    CANCER RESEARCH, 2024, 84 (06)
  • [26] Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD
    Canivet, Clemence M.
    Costentin, Charlotte
    Irvine, Katharina M.
    Delamarre, Adele
    Lannes, Adrien
    Sturm, Nathalie
    Oberti, Frederic
    Patel, Preya J.
    Decaens, Thomas
    Irles-Depe, Marie
    Fouchard, Isabelle
    Hermabessiere, Paul
    Roux, Marine
    Barthelon, Justine
    Cales, Paul
    Powell, Elizabeth E.
    de Ledinghen, Victor
    Boursier, Jerome
    HEPATOLOGY, 2023, 77 (03) : 920 - 930
  • [27] Editorial: Therapeutic and Diagnosis Target Discovery Based on Metabolomics
    Liu, Linsheng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [28] Urine-based ELISA testing for the diagnosis and confirmation of eradication of H. pylori infection
    Dolek, D.
    Soyturk, M.
    Bekmen, N.
    Gonen, C.
    Yilmaz, O.
    Sarioglu, S.
    Demiray, E.
    Ellidokuz, H.
    Simsek, I.
    HELICOBACTER, 2008, 13 (05) : 452 - 452
  • [29] Evaluation of a serum and urine-based ELISA testing distinct antigens for the diagnosis of tegumentary leishmaniasis
    Camara, Raquel S. B.
    Pereira, Isabela A. G.
    Lage, Daniela P.
    Vale, Danniele L.
    Ludolf, Fernanda
    Galvani, Nathalia C.
    Freitas, Camila S.
    Oliveira-da-Silva, Joao A.
    Assis, Barbara P. N.
    Chaves, Ana T.
    Pimenta, Breno L.
    Silva, Marcela G. P.
    Tavares, Grasiele S. V.
    Galdino, Alexsandro S.
    Tupinambas, Unai
    Chavez-Fumagalli, Miguel A.
    Pascoal, Vanessa P. M.
    Eller, Marcela T. C.
    Rocha, Manoel O. da Costa
    Machado-de-Avila, Ricardo A.
    Goncalves, Denise U.
    Coelho, Eduardo A. F.
    MICROBIAL PATHOGENESIS, 2025, 200
  • [30] Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply
    Henson, Jacqueline B.
    Corey, Kathleen E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (10) : 988 - 989